{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/immunizations-travel/how-up-to-date-is-this-topic/changes/","result":{"pageContext":{"chapter":{"id":"2221cdd9-5576-5b5b-ad29-eff077930653","slug":"changes","fullItemName":"Changes","depth":2,"htmlHeader":"<!-- begin field b72e11d6-6bc3-44e9-89c3-7e9713d2c1e5 --><h2>Changes</h2><!-- end field b72e11d6-6bc3-44e9-89c3-7e9713d2c1e5 -->","summary":null,"htmlStringContent":"<!-- begin item e40697bd-f15b-4f6a-84f7-0cc723615f57 --><!-- begin field d2bfdb7d-c0ed-4e56-99f4-90db6273de0b --><p><strong>January to February 2021 </strong>— reviewed. A literature search was conducted in January 2021 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of the topic. No major changes to clinical recommendations have been made.</p><!-- end field d2bfdb7d-c0ed-4e56-99f4-90db6273de0b --><!-- end item e40697bd-f15b-4f6a-84f7-0cc723615f57 -->","topic":{"id":"8f89ca7f-a4f5-5e7d-80c8-de5db64ca7f0","topicId":"16d61716-d647-48bc-827b-b2b115ecd0fb","topicName":"Immunizations - travel","slug":"immunizations-travel","lastRevised":"Last revised in January 2021","chapters":[{"id":"25b90177-7e96-59db-b325-abc5f51c8721","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"bc7c22b0-dd64-50ad-8110-1fff4c8d6736","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"50f55046-7ca2-567f-94df-9c58f13770a5","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"2221cdd9-5576-5b5b-ad29-eff077930653","slug":"changes","fullItemName":"Changes"},{"id":"c755b06c-072d-5e60-be73-155dd664c37d","slug":"update","fullItemName":"Update"}]},{"id":"f5871d9a-dff3-59ce-a611-88d2ec41f5ce","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"513a86a0-e305-5e59-bd0d-1fb74a6e8689","slug":"goals","fullItemName":"Goals"},{"id":"87ea4699-bd41-5aeb-aa62-eac1fb591c4d","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c8b054a0-ee87-5f9e-aa8f-c1fdf8442a29","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"a8eb4582-f05d-5af5-ae78-497260724f93","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"6f29b0b8-4b10-5e26-9ece-4cec050b1eb0","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"79cb1d1a-ebd1-58c6-9bc5-2bfd006c22c1","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"8d3187f5-2a99-5108-a7c9-dd601d729381","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"055aad08-f5af-5b2f-bda0-a35213a2a071","slug":"travel-vaccinations","fullItemName":"Travel vaccinations"},{"id":"c8d1352b-616b-5dff-9517-ea235b83e9d9","slug":"diseases-commonly-requiring-vaccination","fullItemName":"Diseases commonly requiring vaccination"},{"id":"041fa115-033d-5525-91ce-c43dbf593bd4","slug":"other-diseases-requiring-vaccination","fullItemName":"Other diseases requiring vaccination"},{"id":"1fe14ee1-a79f-565a-9380-ae3be597d7d5","slug":"where-these-diseases-are-prevalent","fullItemName":"Where these diseases are prevalent"},{"id":"68e09f74-2282-532f-ae34-064998823fc1","slug":"payment-for-travel-vaccinations","fullItemName":"Payment for travel vaccinations"}]},{"id":"0e45089d-2317-5ec5-8c73-f0709c003c48","fullItemName":"Management","slug":"management","subChapters":[{"id":"9c16c0cb-4e78-523d-914f-e884aea62565","slug":"initial-assessment-advice","fullItemName":"Scenario: Initial assessment and advice"},{"id":"f911dc04-ffd0-5a41-a3cb-b724797a7589","slug":"cholera","fullItemName":"Scenario: Cholera"},{"id":"422ff6d3-5810-5d3c-93b3-c5a67faaa0e1","slug":"hepatitis-a","fullItemName":"Scenario: Hepatitis A"},{"id":"01d49a70-70f4-547a-a551-ab524f99c944","slug":"hepatitis-b","fullItemName":"Scenario: Hepatitis B"},{"id":"5c77503c-2f59-5696-908b-125fe0e8e41c","slug":"japanese-encephalitis","fullItemName":"Scenario: Japanese encephalitis"},{"id":"8cb4ca86-fe31-5603-a75e-84413c2b5346","slug":"meningococcal-meningitis","fullItemName":"Scenario: Meningococcal meningitis"},{"id":"0e84be27-375b-55f5-9f51-d0e4cc422b58","slug":"poliomyelitis","fullItemName":"Scenario: Poliomyelitis"},{"id":"37a96f8b-4158-5e62-8e3d-6cedae506976","slug":"rabies","fullItemName":"Scenario: Rabies"},{"id":"8c237a0e-a760-55b2-b7b0-5383b7653be3","slug":"tetanus","fullItemName":"Scenario: Tetanus"},{"id":"85c90e1f-26f4-503b-b0b0-7c5a38930086","slug":"tick-borne-encephalitis","fullItemName":"Scenario: Tick-borne encephalitis"},{"id":"4e817d26-15f3-5ff7-a672-11caa36ffb68","slug":"typhoid-fever","fullItemName":"Scenario: Typhoid fever"},{"id":"5ec20606-2af2-556b-98a6-d8673a21a09d","slug":"yellow-fever","fullItemName":"Scenario: Yellow fever"},{"id":"e0a021ac-7c76-551a-97af-25341142d54f","slug":"hajj-umrah-pilgrims","fullItemName":"Scenario: Hajj and Umrah pilgrims"},{"id":"087d9fbb-1ec6-5f08-8e76-5df3a4a0b863","slug":"rapid-vaccination-courses-vaccination-at-short-notice","fullItemName":"Scenario: Rapid vaccination courses and vaccination at short notice"}]},{"id":"79dee816-dbdb-5426-8db3-2f095eedbff3","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"f1e9d43f-6815-516a-8511-3fd34a06525d","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"a69fb594-d4b4-56e6-b46a-6283ead93e30","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"52eea726-d50b-5e4f-a22c-764c1961119d","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b2033c1b-25a2-5a58-b99e-00baf9b02a96","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"6df4842b-8812-534e-975d-52d29f3a8ee4","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"81e42472-4b49-5390-8179-0d131f547700","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"86482706-09b2-5113-bd4e-261c392f6483","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"50f55046-7ca2-567f-94df-9c58f13770a5","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"ce8a5e58-52aa-5bac-add9-b38ac006a51b","slug":"previous-changes","fullItemName":"Previous changes","depth":3,"htmlHeader":"<!-- begin field 775cbad2-56b6-4a70-a6d2-a4c32d13aa2d --><h3>Previous changes</h3><!-- end field 775cbad2-56b6-4a70-a6d2-a4c32d13aa2d -->","summary":null,"htmlStringContent":"<!-- begin item 4bd8e7cc-edea-45c8-842f-c343971fd2af --><!-- begin field e2734845-4aca-41f5-944e-f2809d4ffa0f --><p><strong>August 2020 </strong>— minor update. A typographical error has been corrected.</p><p><strong>May 2019 </strong>— minor update. The MHRA have received 2 reports of fatal adverse reactions to the yellow fever vaccine (Stamaril). Due to an increased risk of life-threatening reactions, they advise that the vaccine must not be given to anyone with a medical history of thymus dysfunction or who is immunosuppressed. </p><p><strong>February 2018 </strong>— minor update. Product removed from topic as no longer available.</p><p><strong>September 2017 </strong>— minor update. Information added to adverse effects of TicoVac as per updates to the manufacturers' summary of product characteristics. </p><p><strong>December 2016 </strong>— minor update. Information that the validity of the yellow fever vaccination certificate is now lifelong has been added to this topic WHO, 2016.</p><p><strong>November 2016 </strong>— minor update. A typographical error has been corrected in Table 1, in the background information section of this topic.</p><p><strong>August to October 2016 </strong>— reviewed. A literature search was conducted in August 2016 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of the topic. No major changes to clinical recommendations have been made.</p><p><strong>February 2015 </strong>— two minor updates:</p><ul><li>Meningococcal meningitis vaccine ACWY Vax<sup>®</sup> has been discontinued, Menveo<sup>®</sup> is still available. Scenario updated to reflect the changes.</li><li>Nimemrix<sup>®</sup> is an additional available Meningococcal meningitis ACWY conjugate vaccine and has been added to the relevant scenario.</li></ul><p><strong>December 2014</strong> — minor update to the table regarding countries where poliomyelitis is prevalent based on new World Health Organisation recommendations.</p><p><strong>November 2014</strong> — minor update to the text regarding co-administration of the yellow fever vaccine with the MMR vaccine.</p><p><strong>September 2014</strong> — minor update to the text for rabies vaccinations. People should be given post-exposure rabies vaccination and rabies immunoglobulin.</p><p><strong>April 2014</strong> — minor update. Minor update to the text for rabies vaccination. A booster dose can be considered at 10 years post-primary course for people who are infrequent travellers to high-risk areas.</p><p><strong>January 2013</strong> — minor update. Minor text changes to the Indications for Vaccine section of the Scenario Cholera have been made to reflect minor changes to Public Health England's <em>Immunisation against infectious disease</em> 'The Green Book' Chapter 14: Cholera.</p><p><strong>December 2013</strong> — minor update. Changes to the text in the Scenario: Japanese encephalitis and Prescribing Information sections have been made to reflect policy changes in Public Health England's<em> Immunisation against infectious disease</em> 'The Green Book'. Green Cross<sup>®</sup> vaccine is not licensed or recommended for use in the UK as there is a licensed alternative Japanese encephalitis vaccine (IXIARO<sup>®</sup>) available, and IXIARO<sup>®</sup> vaccine is now licensed for use in infants from 2 months of age.</p><p><strong>April 2013</strong> — minor update. Advice from the Department of Health regarding the use of yellow fever vaccine in women who are breastfeeding has been added.</p><p><strong>September 2012</strong> — minor update. Advice from the National Travel Health Network and Centre (NaTHNaC) for pilgrims for the Hajj and Umrah season of 1433 (2012) has been added.</p><p><strong>August 2012</strong> — reviewed. A literature search was conducted in May 2012 to identify evidence-based guidelines, UK policy, systematic reviews, and key RCTs published since the last revision of this topic. No major changes to recommendations have been made. Updates to the Department of Health publication Immunisation against infectious disease (the Green Book) and the National Travel Health Network and Centre (NaTHNaC) publications have been included.</p><p><strong>June 2012 </strong>— minor update. Minor typographical error corrected.</p><p><strong>April 2011 </strong>— topic structure revised to ensure consistency across CKS topics — no changes to clinical recommendations have been made</p><p><strong>February 2011</strong>— minor update. Brand name of tick-borne encephalitis vaccine corrected to read TicoVac<sup>®</sup>. Issued in February 2011.</p><p><strong>October 2010 </strong>— updated. Advice from the National Travel Health Network and Centre (NaTHNaC) for pilgrims for the Hajj and Umrah season of 1431 (2010) has been added. Issued in November 2010.</p><p><strong>September 2010 </strong>— minor update. A new edition of <em>Health information for overseas travel, </em>the 'Yellow Book', has been published and has been included in this topic. Issued in September 2010.</p><p><strong>August 2010 </strong>— minor update. Menveo<sup>®</sup>, a new quadrivalent meningococcal conjugate vaccine, is now recommended in preference to ACWY Vax<sup>® </sup>(polysaccharide vaccine) for all age groups requiring quadrivalent meningococcal vaccine. Issued in August 2010.</p><p><strong>June 2010 — </strong>minor typographical correction. Issued in June 2010.</p><p><strong>April 2010 </strong>— minor update. Prescriptions amended to indicate which travel vaccinations are not available on the NHS. Issued in April 2010.</p><p><strong>June 2009 </strong>— updated to include information on IXIARO<sup>®</sup>, a Japanese encephalitis vaccine that has a UK product licence. Issued in June 2009.</p><p><strong>November 2008 </strong>— minor update. Black triangle removed from cholera vaccine. Issued in December 2008.</p><p><strong>March to July 2007</strong>— converted from CKS guidance to CKS topic structure. The evidence-base has been reviewed in detail, and recommendations are more clearly justified and transparently linked to the supporting evidence. This CKS topic has been developed following the publication of the 'Green Book' (Immunisation against infectious disease) by the Department of Health.</p><p><strong>August 2008 </strong>— minor update to text regarding Revaxis<sup>® </sup>and Repevax<sup>®</sup>. Issued August 2008.</p><p><strong>May 2008 </strong>— minor update to information on Typhim Vi vaccine. This vaccine is now licensed from 2 years old (previously 18 months). Issued June 2008.</p><p><strong>March 2008 </strong>— minor update to the text to reflect changes in the yellow fever vaccination recommendations for people travelling to Argentina, Brazil, and Paraguay. From 15 December 2007, all yellow fever vaccinations should be documented in the International Certificate of Vaccination or Prophylaxis (ICVP). Issued in March 2008.</p><p><strong>July 2007 </strong>— three minor updates to the text. The age for meningitis vaccine has been changed from three months to two months, minor change to text relating to typhoid, and update to the schedule information for hepatitis B vaccine for health care workers. Minor formatting changes made to the Clinical Summaries on <em>Typhoid fever</em>, <em>Japanese encephalitis</em>, and <em>Vaccination at short notice</em>. Issued in August 2007.</p><p><strong>April 2004 </strong>— written. Validated in March 2004 and issued in June 2004.</p><!-- end field e2734845-4aca-41f5-944e-f2809d4ffa0f --><!-- end item 4bd8e7cc-edea-45c8-842f-c343971fd2af -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}